# Cancer Applications

**Single-Cell Proteomics in Cancer Research**

## Overview

Single-cell proteomics provides unprecedented resolution for understanding tumor heterogeneity, drug resistance mechanisms, and immune microenvironment dynamics.

## Key Applications

### Tumor Heterogeneity
- Identify rare cell populations
- Map clonal evolution
- Detect drug-resistant subclones

### Drug Response
- Single-cell pharmacoproteomics
- Resistance mechanism discovery
- Biomarker identification

### Immune Microenvironment
- T cell exhaustion states
- Macrophage polarization
- Immune checkpoint expression

## Cancer Types Studied

| Cancer | Key Findings | Reference |
|--------|--------------|-----------|
| Triple-Negative Breast Cancer | Cellular diversity, resistance | Nalla et al. 2025 |
| Melanoma | Immune evasion | Multiple studies |
| Leukemia | Differentiation hierarchies | Specht et al. 2021 |
| Lung Cancer | Drug resistance | Emerging |

## Advantages Over Bulk

1. **Detect rare cells**: <1% of population
2. **Avoid averaging**: True distributions
3. **Track dynamics**: Pseudotime analysis
4. **Protein-level**: Post-transcriptional regulation

## Integration Opportunities

- **Multi-omics**: SCP + scRNA-seq
- **Spatial**: Location-aware proteomics
- **Temporal**: Time-course studies

## Challenges

- Limited throughput for clinical samples
- Need for fresh tissue
- Complex data interpretation
- Statistical power considerations

## Key Publications

- Nalla et al. (2025) Proteomics Clin Appl - TNBC review
- Specht et al. (2021) - Macrophage heterogeneity

## Future Directions

- Clinical biomarker discovery
- Patient stratification
- Drug combination optimization
- Minimal residual disease detection

## Tags

#applications #cancer #heterogeneity #clinical
